CYP3A4 and neoplasm: Better diagnostic methods for identifying particularly aggressive tumours, e.g. by new molecular markers, analysis of DNA ploidy or CYP3A4 genotype [57], would increase the effectiveness of AS on account of the reduced number of PC deaths due to under staging [54].